Does short-term low-dose methotrexate treatment affect homocysteine blood level in patients with psoriasis?

ABSTRACT

An elevated homocysteine level is an independent risk factor for cardiovascular disorders. Psoriatic patients have an increased risk of cardiovascular diseases; In addition, hyperhomocysteinemia is a complication of methotrexate treatment. We undertook a study to evaluate the plasma levels of homocysteine, vitamin B12 and folate in patients with psoriasis before and after short-term low-dose methotrexate treatment. Twenty six patients with psoriasis were recruited. The plasma levels of homocysteine, vitamin B12 and folate were evaluated before and 8 weeks after methotrexate therapy [in the peak of methotrexate effect]. No significant difference was found between the plasma profile of homocysteine, vitamin B12 and folate before and after methotrexate treatment. In the short-term treatment of psoriasis, methotrexate does not increase homocysteine level